Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Age and hematologic parameters can predict prolonged glucocorticoid replacement after remission of cushing disease and adrenal Cushing's syndrome: A nationwide cohort study
Pituitary. 2026 Mar 25; 29:
Missed opportunities for risk reduction: type 1 diabetes management in older adults in DPV and T1DX-QI registries
Journal of the Endocrine Society. 2026 Mar ; 10:bvag007
Age-related decline in NCKX4-mediated calcium clearance accelerates aortic remodelling and drives early vascular ageing
The Journal of physiology. 2026 Feb 20;
Defining prediabetes remission as a distinct prevention endpoint
Lancet. Diabetes & endocrinology. 2026 Feb ; 14:100-102
Endothelial Cell Regulation of Lipid Uptake During Feeding and Fasting
Arteriosclerosis, thrombosis, & vascular biology. 2026 Feb ; 46:e323501
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
Lancet. Diabetes & endocrinology. 2026 Feb ; 14:123-136
A novel disposition index without insulin is an earlier and sensitive predictor of type 2 diabetes than current diagnostic criteria
Diabetes research and clinical practice. 2026 Jan 29; 233:113131
Joint Modeling of Longitudinal Biomarker and Survival Outcomes with the Presence of Competing Risk in the Nested Case-Control Studies with Application to the TEDDY Microbiome Dataset
Bioinformatics. 2026 Jan 22;